Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
CHHB is classic patient money because once their digital transformation kicks into gear, the price will surely break out and reward those who keep holding.
Apollo strategy for premium products and better distribution network is solid but everything really hinge on whether their profit margins can tahan the rising cost of ingredients.
Steady lah this one keep quiet wait for cycle recovery because retail sector play always can squeeze out some surprise profit when people start spending again.
Management really need to wake up and take this company private soon because the stagnant share price and lack of growth is honestly just wasting everyone's time compared to what we saw with the Ajinomoto privatization.
